Moderna Highlights JAMA Publication Of Real-World Comparative Effectiveness Data For COVID-19 Vaccine Adults Aged 65 Years and Older
Benzinga Newsdesk 5 hours ago
FDANews
Real-world analysis of more than 294,000 U.S. Veterans aged 65 and older found mNEXSPIKE was associated with a 35.9% lower risk of medically attended COVID-19 and a 47% lower risk of COVID-19-associated hospitalization
Real-world analysis of more than 294,000 U.S. Veterans aged 65 and older found mNEXSPIKE was associated with a 35.9% lower risk of medically attended COVID-19 and a 47% lower risk of COVID-19-associated hospitalization versus Comirnaty (COVID-19 Vaccine, mRNA)